You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》美銀證券下調阿里健康(00241.HK)目標價至19元 評級「買入」
阿思達克 10-27 10:17
美銀證券發表研究報告指,阿里健康(00241.HK)日前發盈警,預期中期虧損不多於3.2億元人民幣,考慮到增長前景及盈利能力下降,在增長前景下調的情況下,將目標價從23元降至19元。 該行將2022上半財年收入預測下調至94億元人民幣,增幅由早前的39%降至31%,預期母公司阿里巴巴(09988.HK)截至9月底止年度活躍用戶增長放緩至10%,預計阿里健康在阿里巴巴用戶的滲透率將基本穩定在36%,流量增長回復正常化。 同時,由於阿里健康的周年慶活動從9月推遲到10月,加上低基數和創新業務貢獻,美銀預計下半財年的增長將有所改善,預計其將繼續受惠於線上滲透率提升,重申「買入」評級。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account